These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1516285)

  • 21. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
    César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
    Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
    [No Abstract]   [Full Text] [Related]  

  • 22. [Surgical arteriovenous fistula permitting the performance of periodic hemodialysis by rpeated venous puncture and a plate type artificial kidney (preliminary note)].
    Suc JM; Escat J; Ton That H; Mériel P; Conte J; Malvy F; Lepert F
    J Urol Nephrol (Paris); 1967; 73(10):802-10. PubMed ID: 5596275
    [No Abstract]   [Full Text] [Related]  

  • 23. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of heparin-induced thrombocytopenia type II in hemodialysis patients: the search for a Holy Grail continues.
    Goździkiewicz J; Borawski J; Myśliwiec M
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):110-1. PubMed ID: 17164502
    [No Abstract]   [Full Text] [Related]  

  • 25. Subclavian vein stenosis: complication of subclavian vein catheterization for hemodialysis.
    Lee SJ; Neiberger R
    Child Nephrol Urol; 1991; 11(4):212-4. PubMed ID: 1777904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrieval of a fractured piece of Tessio catheter with a snare using a transcutaneous transvenous approach.
    Zaman F; Pervez A; Murphy S; Abreo KD
    Semin Dial; 2005; 18(4):343-4. PubMed ID: 16076359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombosis and stenosis of central venous access in hemodialysis].
    Vanherweghem JL
    Nephrologie; 1994; 15(2):117-21. PubMed ID: 8047195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approach to vascular access revascularisation: the Hydrolyser Thrombectomy Catheter.
    Martinez JF; Momblanch T; Pallares M; Alonso J; Sanz A; Marti A
    EDTNA ERCA J; 1996; 22(4):26-8. PubMed ID: 10723345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Superior vena cava thrombosis in a patient on hemodialysis].
    Saval N; Pou M; López Pedret J; Burrell M; Cases A
    Nefrologia; 2004; 24 Suppl 3():35-8. PubMed ID: 15219066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium heparin-induced immunologic thrombocytopenia complicated with venous gangrene of the legs. Report of a clinical case].
    Perfetto F; Chessa GC; Petri I; Cammilli A
    Ann Ital Med Int; 2001; 16(3):179-84. PubMed ID: 11692908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute limb ischemia secondary to heparin-induced thrombocytopenia after cardiac surgery.
    Kreidy R; Hatem J
    J Med Liban; 2004; 52(3):175-81. PubMed ID: 16432978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors.
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Nephron Clin Pract; 2007; 107(4):c128-32. PubMed ID: 17957123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful renal transplantation in a patient with heterozygous prothrombin gene, factor V Leiden mutation and heparin-induced thrombocytopenia using r-hirudin as anticoagulant.
    John U; Kentouche K; Nowak G; Schubert J; Misselwitz J
    Pediatr Transplant; 2006 Feb; 10(1):114-8. PubMed ID: 16499600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombocytopenia and anaphylaxis secondary to heparin in a hemodialysis patient.
    Tejedor Alonso MA; López Revuelta K; García Bueno MJ; Casas Losada ML; Rosado Ingelmo A; Gruss Vergara E; Vila Albelda C; Moro Moro M
    Clin Nephrol; 2005 Mar; 63(3):236-40. PubMed ID: 15786828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clotting by heparin of hemoaccess for hemodialysis in an end-stage renal disease patient.
    Pham PT; Miller JM; Demetrion G; Lew SQ
    Am J Kidney Dis; 1995 Apr; 25(4):642-7. PubMed ID: 7702065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
    Ng HJ; Than H; Teo EC
    Thromb Res; 2015 Jan; 135(1):205-7. PubMed ID: 24974053
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term heparinization in the treatment of chronic renal failure with intermittent hemodialysis].
    Kiriakov Z; Otsetova S
    Khirurgiia (Sofiia); 1972; 25(4):357-9. PubMed ID: 4651368
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypersensitivity to heparin; a case report.
    Katoh S; Terashima S; Nakahara Y; Yamada H; Tatsukawa H; Ida K; Nakagawa M
    Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):411-4. PubMed ID: 8341021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.